Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer.

Am J Physiol Heart Circ Physiol 2019 Jul 19;317(7):H1-H12. Epub 2019 Apr 19.

Heart Institute (InCor), University of São Paulo Medical School , São Paulo , Brazil.

The purpose of the present study was to test the hypothesis that doxorubicin (DX) and cyclophosphamide (CY) adjuvant chemotherapy (CHT) acutely impairs neurovascular and hemodynamic responses in women with breast cancer. Sixteen women (age: 47.0 ± 2.0 yr; body mass index: 24.2 ± 1.5 kg/m) with stage II-III breast cancer and indication for adjuvant CHT underwent two experimental sessions, saline (SL) and CHT. In the CHT session, DX (60 mg/m) and CY (600 mg/m) were administered over 45 min. In the SL session, a matching SL volume was infused in 45 min. Muscle sympathetic nerve activity (MSNA) from peroneal nerve (microneurography), calf blood flow (CBF; plethysmography) and calf vascular conductance (CVC), heart rate (HR; electrocardiography), and beat-to-beat blood pressure (BP; finger plethysmography) were measured at rest before, during, and after each session. Venous blood samples (5 ml) were collected before and after both sessions for assessment of circulating endothelial microparticles (EMPs; flow cytometry), a surrogate marker for endothelial damage. MSNA and BP responses were increased ( < 0.001), whereas CBF and CVC responses were decreased ( < 0.001), during and after CHT session when compared with SL session. Interestingly, the vascular alterations were also observed at the molecular level through an increased EMP response to CHT ( = 0.03, CHT vs. SL session). No difference in HR response was observed ( > 0.05). Adjuvant CHT with DX and CY in patients treated for breast cancer increases sympathetic nerve activity and circulating EMP levels and, in addition, reduces muscle vascular conductance and elevates systemic BP. These responses may be early signs of CHT-induced cardiovascular alterations and may represent potential targets for preventive interventions. It is known that chemotherapy regimens increase the risk of cardiovascular events in patients treated for cancer. Here, we identified that a single cycle of adjuvant chemotherapy with doxorubicin and cyclophosphamide in women treated for breast cancer dramatically increases sympathetic nerve activity and circulating endothelial microparticle levels, reduces the muscle vascular conductance, and elevates systemic blood pressure.

Download full-text PDF

Source
https://www.physiology.org/doi/10.1152/ajpheart.00756.2018
Publisher Site
http://dx.doi.org/10.1152/ajpheart.00756.2018DOI Listing
July 2019
6 Reads

Publication Analysis

Top Keywords

breast cancer
20
nerve activity
12
vascular conductance
12
sympathetic nerve
12
cht session
12
patients treated
8
muscle vascular
8
reduces muscle
8
adjuvant cht
8
treated breast
8
cht
8
circulating endothelial
8
adjuvant chemotherapy
8
activity circulating
8
increases sympathetic
8
doxorubicin cyclophosphamide
8
blood pressure
8
conductance elevates
8
hemodynamic responses
8
neurovascular hemodynamic
8

References

(Supplied by CrossRef)

Similar Publications